Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;10(11):2125-2132.
doi: 10.21037/qims-20-369.

The application of a targeted periprostatic nerve block in transperineal template-guided prostate biopsies

Xue-Fei Ding  1 , Yang Luan  1 , Fei Wang  1 , Yao-Zong Xu  1 , Cheng-Hao Guo  1 , Liang-Yong Zhu  1
Affiliations

The application of a targeted periprostatic nerve block in transperineal template-guided prostate biopsies

Xue-Fei Ding et al. Quant Imaging Med Surg. 2020 Nov.

Abstract

Background: Our study aims to evaluate the anesthetic efficacy of multiparametric magnetic resonance imaging/transrectal ultrasound (mpMRI/TRUS) fusion-guided targeted periprostatic nerve block (PNB) for transperineal template-guided prostate biopsy (TTPB).

Methods: The patients who underwent mpMRI/TRUS fusion-guided prostate biopsy from May 2018 to March 2019 were randomized into two groups using a random number table. The intervention group (n=47) and the control group (n=45) received targeted PNB and traditional PNB, respectively. Visual analog scale (VAS) and visual numeric scale (VNS) scores were used to assess the patients' pain and quantify their satisfaction.

Results: The total detection rate for prostate cancer was 45.7%, with a comparable positive rate between the intervention group (42.6%) and the control group (48.9%), which meant there was no significant difference between the groups (P=0.542). Patient age, prostate-specific antigen, prostate volume, suspicious lesions on mpMRI, number of cores, operation time, and biopsy time were comparable between the groups. The VAS scores during biopsy were significantly lower in the intervention group than in the control group [2 (1 to 3) vs. 2 (1 to 4), P=0.019]. Conversely, the VNS scores during biopsy were higher in the intervention group [3 (2 to 4) vs. 3 (2 to 3), P=0.015]. There were no significant differences in the pain scores or the satisfaction scores at 30 min after the procedure between the two groups. There were no significant differences between the groups for complications, such as hematuria, urinary retention, infection, hemospermia, and vasovagal reaction (P>0.05).

Conclusions: Targeted PNB significantly relieved the pain and did not increase the incidence of complications for patients when compared with traditional PNB.

Keywords: Magnetic resonance imaging (MRI); biopsy; nerve block; prostate.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/qims-20-369). The authors have no conflicts of interest to declare

Figures

Figure 1
Figure 1
mpMRI/TRUS image fusion. (A) Multiple sequences of mpMRI, the regions of interest are delineated on T2WI. The prostate target is contoured in purple. The suspected area of prostate cancer target is contoured in blue. The bilateral NVB target is contoured in yellow and red, respectively. (B) The reconstructed MRI axial images are synchronously displayed adjacent to the TRUS axial image on the same monitor. With the brightness of MRI image adjusted, the MRI image with a red background can be seen behind the TRUS image, and the goodness of fit between the MRI and the TRUS image could be observed and adjusted. (C,D)Targeted PNB was performed under the guidance of the mpMRI/TRUS image fusion. Infiltrative anesthesia for NVB in yellow and red contours was performed, respectively. The bright white spots inside yellow (C) and red (D) contours were the needlepoint of the ANSll 0.5 mm × 112 mm spinal needle.
Figure 2
Figure 2
The flow diagram of the study according to the Consolidated Standards of Reporting Trials (CONSORT) guidelines.
See this image and copyright information in PMC

References

    1. Li M, Chen T, Zhao W, Wei C, Li X, Duan S, Ji L, Lu Z, Shen J. Radiomics prediction model for the improved diagnosis of clinically significant prostate cancer on biparametric MRI. Quant Imaging Med Surg 2020;10:368-79. 10.21037/qims.2019.12.06 - DOI - PMC - PubMed
    1. Muthuveloe D, Telford R, Viney R, Patel P. The detection and upgrade rates of prostate adenocarcinoma following transperineal template-guided prostate biopsy - a tertiary referral centre experience. Cent European J Urol 2016;69:42-7. - PMC - PubMed
    1. Mai Z, Xiao Y, Yan W, Zhou Y, Zhou Z, Liang Z, Ji Z, Li H. Comparison of lesions detected and undetected by template-guided transperineal saturation prostate biopsy. BJU Int 2018;121:415-20. 10.1111/bju.13977 - DOI - PubMed
    1. Udeh EI, Amu OC, Nnabugwu II, Ozoemena O. Transperineal versus transrectal prostate biopsy: our findings in a tertiary health institution. Niger J Clin Pract 2015;18:110-4. - PubMed
    1. Bingqian L, Peihuan L, Yudong W, Jinxing W, Zhiyong W. Intraprostatic local anesthesia with periprostatic nerve block for transrectal ultrasound guided prostate biopsy. J Urol 2009;182:479-83; discussion 483-4. 10.1016/j.juro.2009.04.029 - DOI - PubMed